Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
68.15
+0.60 (0.89%)
Nov 26, 2025, 4:00 PM EST - Market closed

Cytokinetics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
225.4794.86113.0265.58112.6782.99
Upgrade
Short-Term Investments
737.07981.16501.8717358.97381.08
Upgrade
Cash & Short-Term Investments
962.541,076614.82782.58471.64464.06
Upgrade
Cash Growth
-4.86%75.01%-21.44%65.93%1.63%106.15%
Upgrade
Accounts Receivable
1.8116.651.280.1556.826.92
Upgrade
Receivables
1.8116.651.280.1556.826.92
Upgrade
Prepaid Expenses
13.0115.2811.9412.467.223.24
Upgrade
Total Current Assets
977.351,108628.05795.19535.67474.22
Upgrade
Property, Plant & Equipment
153.58140.97147.74163.19146.4116.27
Upgrade
Long-Term Investments
288.82145.0640.5346.71152.0536.95
Upgrade
Other Long-Term Assets
16.817.7189.697.196.36
Upgrade
Total Assets
1,4371,402824.321,015841.32533.8
Upgrade
Accounts Payable
22.0820.3721.5125.6121.098.05
Upgrade
Accrued Expenses
61.6355.3242.6444.134.3719.32
Upgrade
Short-Term Debt
16.911.3----
Upgrade
Current Portion of Long-Term Debt
17.2811.5210.080.96--
Upgrade
Current Portion of Leases
20.6519.1817.8912.8314.862.79
Upgrade
Current Unearned Revenue
1.6152.37----
Upgrade
Other Current Liabilities
1.999.6110.561.121.541.05
Upgrade
Total Current Liabilities
142.14179.67102.6884.6271.8631.2
Upgrade
Long-Term Debt
1,185768.6607.37609.62142.84135.71
Upgrade
Long-Term Leases
110.66112.58120.43126.9112.230.44
Upgrade
Long-Term Unearned Revenue
504.5462.19379.98300.5266.07253.07
Upgrade
Other Long-Term Liabilities
15.61140.191.044.46-
Upgrade
Total Liabilities
1,9581,5371,2111,123597.46420.42
Upgrade
Common Stock
0.120.120.10.090.080.07
Upgrade
Additional Paid-In Capital
2,7822,5641,7261,4821,4521,105
Upgrade
Retained Earnings
-3,304-2,702-2,112-1,586-1,208-992.31
Upgrade
Comprehensive Income & Other
0.032.4-0.01-3.59-0.870.15
Upgrade
Shareholders' Equity
-521.12-135.37-386.32-107.9243.86113.38
Upgrade
Total Liabilities & Equity
1,4371,402824.321,015841.32533.8
Upgrade
Total Debt
1,350923.18755.77750.3269.93138.94
Upgrade
Net Cash (Debt)
-387.72152.83-140.9532.28201.71325.12
Upgrade
Net Cash Growth
----84.00%-37.96%265.13%
Upgrade
Net Cash Per Share
-3.261.36-1.460.362.625.04
Upgrade
Filing Date Shares Outstanding
122.26118.4110395.1684.8671.11
Upgrade
Total Common Shares Outstanding
122.26118.21101.6494.8384.871.02
Upgrade
Working Capital
835.21928.27525.37710.57463.81443.02
Upgrade
Book Value Per Share
-4.26-1.15-3.80-1.142.881.60
Upgrade
Tangible Book Value
-521.12-135.37-386.32-107.9243.86113.38
Upgrade
Tangible Book Value Per Share
-4.26-1.15-3.80-1.142.881.60
Upgrade
Machinery
-30.8228.1628.4527.4822.99
Upgrade
Construction In Progress
-4.070.220.740.229.13
Upgrade
Leasehold Improvements
-66.8766.8765.9160.345.87
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q